Skip to main content
Log in

Manage vulvodynia using a multimodal and individualized approach

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Vulvodynia (i.e. vulvar pain lasting ≥ 3 months) is common, but is often not correctly diagnosed. Causative factors and pain profiles are varied and a multimodal approach to management, starting with non-pharmacological interventions, is recommended. Cognitive behaviour therapy and pelvic floor physical therapy are first-line treatments for most cases. Pharmacological options, including anti-nociceptive, anti-inflammatory and neuromodulating agents, warrant further investigation. Surgical vestibulectomy is an effective option in women with localized provoked vulvodynia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bornstein J, Goldstein A, Stockdale CK, et al. 2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. Obstet Gynecol. 2016;127:745–51.

    Article  Google Scholar 

  2. Rosen NO, Dawson SJ, Brooks M, et al. Treatment of vulvodynia: pharmacological and non-pharmacological approaches. Drugs. 2019;79(5):483–93.

    Article  CAS  Google Scholar 

  3. Goldstein A, Pukall CF, Brown C, et al. Vulvodynia: assessment and treatment. J Sex Med. 2016;13:572–90.

    Article  Google Scholar 

  4. Spoelstra SK, Dijkstra JR, van Driel MF, et al. Long-term results of an individualized, multifaceted, and multidisciplinary therapeutic approach to provoked vestibulodynia. J Sex Med. 2011;8:489–96.

    Article  Google Scholar 

  5. McDonald JS, Rapkin AJ. Multilevel local anesthetic nerve blockade for the treatment of generalized vulvodynia: a pilot study. J Sex Med. 2012;9:2919–26.

    Article  Google Scholar 

  6. Rapkin AJ, McDonald JS, Morgan M. Multilevel local anesthetic nerve blockade for the treatment of vulvar vestibulitis syndrome. Am J Obstet Gynecol. 2008;198:e1–5.

    Article  Google Scholar 

  7. Horowitz BJ. Interferon therapy for condylomatous vulvitis. Obstet Gynecol. 1989;73:446–8.

    CAS  PubMed  Google Scholar 

  8. Glazer HI, Rodke G, Swencionis C, et al. Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature. J Reprod Med. 1995;40:283–90.

    CAS  PubMed  Google Scholar 

  9. Langlais EL, Lefebvre J, Maheux-Lacroix S, et al. Treatment of secondary vestibulodynia with conjugated estrogen cream: a pilot, double-blind, randomized placebo-controlled Trial. J Obstetr Gynaecol Can. 2017;39:453–8.

    Article  Google Scholar 

  10. Burrows LJ, Goldstein AT. The treatment vestibulodynia with topical estradiol and testosterone. J Sex Med. 2013;1:30–3.

    Article  CAS  Google Scholar 

  11. Bergeron S, Khalifé S, Dupuis MJ, et al. A randomized clinical trial comparing group cognitive-behavioral therapy and a topical steroid for women with dyspareunia. J Consult Clin Psychol. 2016;84:259–68.

    Article  Google Scholar 

  12. Foster DC, Kotok MB, Huang LS, et al. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2010;116:583–93.

    Article  CAS  Google Scholar 

  13. Danielsson I, Torstensson T, Brodda-Jansen G, et al. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scand. 2006;85:1360–7.

    Article  Google Scholar 

  14. Zyczynski HM, Culbertson S, Gruss J, et al. Substance P and the pathophysiology of vulvar vestibulitis. J Soc Gynecol Investig. 1997;4:107A.

    Google Scholar 

  15. Brown CS, Wan J, Bachmann G, et al. Self-management, amitriptyline, and amitriptyline plus triamcinolone in the management of vulvodynia. J Women Health. 2009;18:163–9.

    Article  Google Scholar 

  16. Munday PE. Treatment of vulval vestibulitis with a potent topical steroid. Sex Transm Infect. 2004;80:154–5.

    Article  CAS  Google Scholar 

  17. Brown CS, Bachmann GA, Wan J, et al. Gabapentin for the treatment of vulvodynia: a randomized controlled trial. Obstet Gynecol. 2018;131:1000–7.

    Article  CAS  Google Scholar 

  18. Friedman M, Ben-David B, Siegler E. Amitriptyline vs. placebo for treatment of vulvodynia: a prospective study. J Lower Genit Tract Dis. 1999;3:36.

    Article  CAS  Google Scholar 

  19. Petersen CD, Giraldi A, Lundvall L, et al. Botulinum toxin type A: a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. J Sex Med. 2009;6:2523–37.

    Article  CAS  Google Scholar 

  20. Bazin S, Lefebvre J, Fortier M, et al. Evaluation of an estrogen vaginal cream for the treatment of dyspareunia: a double-blind randomized trial. J Obstetr Gynaecol Can. 2011;33:838–43.

    Article  Google Scholar 

  21. Morin M, Carroll MS, Bergeron S. Systematic review of the effectiveness of physical therapy modalities in women with provoked vestibulodynia. Sex Med Rev. 2017;5:295–322.

    Article  Google Scholar 

  22. Bergeron S, Binik YM, Khalife S, et al. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain. 2001;91:297–306.

    Article  CAS  Google Scholar 

  23. Masheb RM, Kerns RD, Lozano C, et al. A randomized clinical trial for women with vulvodynia: cognitive-behavioral therapy vs supportive psychotherapy. Pain. 2009;141:31–40.

    Article  Google Scholar 

  24. Corsini-Munt S, Bergeron S, Rosen NO, et al. Feasibility and preliminary effectiveness of a novel cognitivebehavioral couple therapy for provoked vestibulodynia: a pilot study. J Sex Med. 2014;11:2515–27.

    Article  Google Scholar 

  25. Brotto LA, Basson R, Smith KB, et al. Mindfulness-based group therapy for women with provoked vestibulodynia. Mindfulness. 2015;6:417–32.

    Article  Google Scholar 

  26. Murina F, Felice R, Di Francesco S, et al. Vaginal diazepam plus transcutaneous electrical nerve stimulation to treat vestibulodynia: a randomized controlled trial. Eur J Obstetr Gynecol Reprod Biol. 2018;228:148–53.

    Article  CAS  Google Scholar 

  27. Murina F, Bianco V, Radici G, et al. Transcutaneous electrical nerve stimulation to treat vestibulodynia: a randomised controlled trial. BJOG Int J Obstetr Gynaecol. 2008;115:1165–70.

    Article  CAS  Google Scholar 

  28. Morin A, Léonard G, Gougeon V, et al. Efficacy of transcranial direct-current stimulation in women with provoked vestibulodynia. Am J Obstetr Gynecol. 2017;216:584-e1.

    Article  Google Scholar 

  29. McKay E, Kaufman RH, Doctor U, et al. Treating vulvar vestibulitis with electromyographic biofeedback of pelvic floor musculature. J Reprod Med. 2001;46:337–42.

    CAS  PubMed  Google Scholar 

  30. Idama DW, Pring T. Vaginal dilator therapy: an outpatient gynaecological option in the management of dyspareunia. J Obstet Gynaecol. 2000;20:303–5.

    Article  CAS  Google Scholar 

  31. Smith M, Gillmer K. Amielle vaginal trainers: a patient evaluation. J Obstet Gynaecol. 1998;18:146–7.

    Article  CAS  Google Scholar 

  32. FitzGerald MP, Anderson RU, Potts J, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2013;189:175–85.

    Article  Google Scholar 

  33. Goldfinger C, Pukall CF, Thibault-Gagnon S, et al. Effectiveness of cognitive-behavioral therapy and physical therapy for provoked vestibulodynia: a randomized pilot study. J Sex Med. 2016;13:88–94.

    Article  Google Scholar 

  34. Tommola P, Unkila-Kallio L, Paavonen J. Surgical treatment of vulvar vestibulitis: a review. Acta Obstet Gynecol Scand. 2010;89:1385–95.

    Article  Google Scholar 

  35. Tommola P, Unkila-Kallio L, Paavonen J. Long-term well-being after surgical or conservative treatment of severe vulvar vestibulitis. Acta Obstet Gynecol Scand. 2012;91:1086–93.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Consortia

Ethics declarations

Conflict of interest

The article was adapted from Drugs 2019;79(5):483–93 [2] by employees of Adis International Ltd./Springer Nature, who are responsible for the article content and declare no conflicts of interest.

Funding

The preparation of this review was not supported by any external funding.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adis Medical Writers. Manage vulvodynia using a multimodal and individualized approach. Drugs Ther Perspect 35, 612–617 (2019). https://doi.org/10.1007/s40267-019-00678-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-019-00678-w

Navigation